Fair call, then on balance I would have to go with it being a yes.
I would think it a strange way to operate for the FDA to leave it until the approval date to suddenly raise product quality or clinical issues after having had opportunity at the mid-cycle review....but I guess weirder things happen...Might be a mixed bag announcement...
Ann: Trading Halt, page-108
-
- There are more pages in this discussion • 209 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.8¢ |
Change
-0.018(4.79%) |
Mkt cap ! $559.1M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 34.8¢ | $1.500M | 4.234M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 259936 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 331449 | 6 |
View Market Depth
| Last trade - 10.55am 26/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |